PubRank

F Gonzalez-Scarano

Author PubWeight™ 66.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol 1989 2.77
2 Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991 2.77
3 Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proc Natl Acad Sci U S A 1989 2.66
4 Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992 2.41
5 Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A 1993 1.96
6 Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A 1991 1.80
7 Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol 1990 1.65
8 Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol 1996 1.50
9 Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response. J Infect Dis 1978 1.46
10 Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest 1984 1.44
11 Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol 1993 1.37
12 Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986 1.29
13 Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology 1993 1.27
14 Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology 1988 1.26
15 Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis 1994 1.24
16 Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology 1982 1.23
17 Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1988 1.18
18 Completion of the La Crosse virus genome sequence and genetic comparisons of the L proteins of the Bunyaviridae. Virology 1995 1.16
19 Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol 1995 1.13
20 Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology 1993 1.13
21 An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol 1985 1.12
22 Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology 1994 1.09
23 Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu Rev Microbiol 1993 1.08
24 Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J Virol 1991 1.03
25 Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. J Biol Chem 1994 1.03
26 Virulence of La Crosse virus is under polygenic control. J Virol 1986 1.02
27 A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science 1987 1.02
28 The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol 1989 1.01
29 La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology 1985 1.00
30 Replication of a macrophage-tropic strain of human immunodeficiency virus type 1 (HIV-1) in a hybrid cell line, CEMx174, suggests that cellular accessory molecules are required for HIV-1 entry. J Virol 1993 0.99
31 Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 1995 0.98
32 Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J Virol 1993 0.98
33 Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann Neurol 1989 0.97
34 Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup. Virology 1995 0.96
35 Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol 1987 0.96
36 Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J Virol 1995 0.94
37 Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann Neurol 1979 0.93
38 Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B. J Acquir Immune Defic Syndr Hum Retrovirol 1995 0.93
39 La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology 1984 0.91
40 Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones. J Virol 1990 0.91
41 HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res Hum Retroviruses 1993 0.90
42 Human immunodeficiency virus: an agent that defies vaccination. Adv Vet Sci Comp Med 1989 0.90
43 Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site. Virology 1985 0.89
44 GalCer, CD26 and HIV infection of intestinal epithelial cells. AIDS 1994 0.88
45 Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses. Prog Clin Biol Res 1983 0.86
46 HIV-associated neuropathies: role of HIV-1, CMV, and other viruses. J Peripher Nerv Syst 2001 0.85
47 Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994 0.85
48 Replication in cultured C2C12 muscle cells correlates with the neuroinvasiveness of California serogroup bunyaviruses. Virology 1994 0.84
49 Entry of human immunodeficiency virus-1 into glial cells proceeds via an alternate, efficient pathway. J Leukoc Biol 1991 0.83
50 Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation. J Gen Virol 1994 0.83
51 Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. AJNR Am J Neuroradiol 1996 0.83
52 Pathogenesis of HIV encephalopathy. Ann N Y Acad Sci 1994 0.82
53 HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use. J Virol Methods 1993 0.82
54 Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells. Virology 1994 0.82
55 MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992 0.81
56 Biological studies of the fusion function of California serogroup Bunyaviruses. Microb Pathog 1986 0.80
57 Infection of cultured human adrenal cells by different strains of HIV. AIDS 1992 0.75
58 Monoclonal anti-idiotypic antibodies that mimic the epitope on gp120 defined by anti-HIV-1 monoclonal antibody 0.5 beta. AIDS 1993 0.75
59 Primary epiduritis. Hum Pathol 1981 0.75